Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Eoganachton Jan 26, 2020 1:54pm

159 Views

Post# 30600278

RE:RE:Emerging therapies for BCG-unresponsive disease

There's that. There's the safety profile. And there will be the undeniable efficacy results in the phase 2. The rest of the world just needs to catch up to Laserstock29.

LaserStock29 wrote: Luckily we know the commercial viability of these drugs as they pertain to implementation in hospital. Theres absolutely zero necessity for tld1433 to be compared to say vicinium which has 20-50 instillations. Just on administration load and patient load we win by default.

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features